Novo Nordisk Gets CDSCO Panel Nod To Import, Market Concizumab Injection Dr. Divya Colin5 March 2025 6:00 PM ISTNew Delhi: Citing that there is unmet medical need in the country for the proposed indication, the Subject Expert Committee (SEC) functional under the...
Novo Nordisk Gets CDSCO Panel Nod To study CDR132L Dr. Divya Colin23 Feb 2025 6:00 PM ISTNew Delhi: Novo Nordisk has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
CDSCO Panel Approves Novo Nordisk Proposal Amendment Proposal for Etavopivat study Dr. Divya Colin9 Feb 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Approves Novo Nordisk Protocol Amendment Proposal for Concizumab study Dr. Divya Colin7 Feb 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
FDA approves Semaglutide for renal protection among diabetes patients with CKD Dr. Kamal Kant Kohli30 Jan 2025 9:00 AM ISTNovo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk of worsening kidney...
Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease Ruchika Sharma29 Jan 2025 1:30 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...
Novel Obesity Drug Induces Weight Loss Up to 22% with No Safety Concerns in clinical trial Dr. Kamal Kant Kohli27 Jan 2025 10:00 AM ISTIn a phase 1b/2a trial subcutaneous amycretin demonstrated a safety profile similar to other incretin-based drugs . Adults with obesity experienced...
Novo Nordisk, Valo Health expand collaboration to discover, develop novel treatments for cardiometabolic diseases Ruchika Sharma12 Jan 2025 12:00 PM ISTLexington: Novo Nordisk A/S and Valo Health, Inc. have announced they have entered into an expanded agreement to discover and develop novel...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Novo Nordisk bleeding disorder injection gets USFDA nod Ruchika Sharma21 Dec 2024 11:30 AM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) injection as a...
Novavax to sell Bohumil manufacturing facility to Novo Nordisk for USD 200 million Ruchika Sharma4 Dec 2024 4:56 PM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced that it has signed a...
Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients Farhat Nasim20 Nov 2024 1:36 PM ISTThe move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has yet to launch it.
